In Vitro Ceftriaxone Susceptibility in Methicillin-Susceptible Staphylococcus aureus | Zendy

Kady Phe | Zendy; Dorothy Dao | Zendy; Hannah R. Palmer | Zendy; Vincent H. Tam | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vitro Ceftriaxone Susceptibility in Methicillin-Susceptible Staphylococcus aureus

Author(s) -

Kady Phe,

Dorothy Dao,

Hannah R. Palmer,

Vincent H. Tam

Publication year - 2014

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.04531-14

Subject(s) - ceftriaxone , staphylococcus aureus , microbiology and biotechnology , in vitro , antibiotics , antibacterial agent , medicine , methicillin resistant staphylococcus aureus , micrococcaceae , biology , bacteria , biochemistry , genetics

Staphylococcus aureus is a leading cause of invasive infections in both hospital and community settings. Beta-lactams, specifically oxacillin, nafcillin, and cefazolin, are the drugs of choice against methicillin-susceptible Staphylococcus aureus (MSSA). At our institution, ceftriaxone is commonly

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research